CSF3 and chronic myelomonocytic leukemia: The present study describes a case of CR without relapse nine months after the administration of a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor (G-CSF) (CAG) in an elderly patient with AML transformed from chronic myelomonocytic leukemia (CMML) (6).